Fas ligand - A double-edged sword

Nature Biotechnology

Volumn 16, Issue 11, 1998, Pages 1011-1012

  Chen, Youhai ^a   Wilson, James M ^b,c  

^a Department of Molecular and Cellular Engineering ^*

^b Institute for Human Gene Therapy   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

ANIMAL; ANTIGEN PRESENTING CELL; APOPTOSIS; BIOTECHNOLOGY; CYTOLOGY; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; METHODOLOGY; NOTE; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; BIOTECHNOLOGY; FAS LIGAND PROTEIN; GENE THERAPY; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES;

EID: 0032200573     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/3455     Document Type: Article

References (9)

1. Wilson, J.M. 1993. Nature 365:691-692.
2. Zhang, H.-G., et al. Nat. Biotechnol. 16:1045-1049.
3. Nagata, S. and Golstein, P. 1995. Science 267:1449-1456.
4. Lau, H.T., Yu, M., Fontana, A., and Stoeckert, C.J., Jr. 1996. Science 273:109-112.
5. Zhang, H., et al. 1997. J. Clin. Invest. 100:1951-1957.
6. Saas, P., et al. 1997. J. Clin. Invest. 99:1173-1178.
7. Giordano, C., et al. 1997. Science 275:960-963.
8. Chervonsky, A.V., et al. 1997. Cell 89:17-24.
9. Kang, S.M., et al.1997. Nat. Med. 3:738-743.